Now accepting speaker proposals - e-mail erica.feinberg@informa.com

Stay at the forefront of Seattle’s cancer treatment trends and technologies that are fueling today’s biotech investment and partnership opportunities

There is an outsize presence of cancer work in Seattle compared to other regions, and the investment in personalized diagnostics has grown considerably in the past year. But once companies get big enough to have an impact, they are often acquired like homegrown Juno and Immune Design. What does it take to have a successful merger? And how are acquisitions affecting the life science ecosystem in Seattle?
 

All registrations include access to the attendee networking app
Learn more or watch a demonstration video:


 

 
Who should attend: life science innovators, executives, entrepreneurs, investors, and scientists.
 
Xconomy’s premier event series is strategically positioned within the six key U.S. life science hubs: San Diego, Boston, Philadelphia, San Francisco, Seattle, and New York. Each event facilitates partnerships and innovation through networking, while bringing the news to life. Join us as we spotlight trendsetting scientists, executives, and entrepreneurs from each region, with a focus on research and development, funding and deal making, technologies and services, and markets and regulations.

“Xconomy appears to have a good pulse on the biopharma industry."
- Recent Xcelerating Life Sciences Attendee

Xcelerating Life Sciences Seattle - A biotech conference & networking event focused on personalized medicine in oncology diagnostics & therapeutics

Spark inspiration, make connections & create impact
Sign up for Xconomy event alerts & newsletters